Treating Primary Liver Cancer with Hepatic Arterial Infusion of Floxuridine and Dexamethasone: Does the Addition of Systemic Bevacizumab Improve Results

Publisher： Karger

E-ISSN： 1423-0232|80|3-4|153-159

ISSN： 0030-2414

Source： Oncology, Vol.80, Iss.3-4, 2011-06, pp. : 153-159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatic Arterial Infusion with Irinotecan, Oxaliplatin, and Floxuridine plus Systemic Chemotherapy as First-Line Treatment of Unresectable Liver Metastases from Colorectal Cancer

By  

Oncology Research and Treatment, Vol. 35, Iss. 9, 2012-08 ,pp. : 480-484

Karger

Access to resources Recommend Favorite

HAIC for liver metastases from CRC

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. 1, 2015-03 ,pp. : 41-48

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatic Arterial Chemotherapy for Colorectal Cancer Metastatic to the Liver

By  

Oncology, Vol. 59, Iss. 2, 2000-08 ,pp. : 89-97

Karger

Access to resources Recommend Favorite

Infusion of DDAVP does not improve primary hemostasis in patients with cirrhosis

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 7, 2015-07 ,pp. : 1809-1815

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adjuvant Systemic Chemotherapy with or without Bevacizumab in Patients with Resected Liver Metastases from Colorectal Cancer

By  

Oncology, Vol. 84, Iss. 1, 2012-10 ,pp. : 14-21

Karger

Access to resources Recommend Favorite